Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives
Yuqiu Han, Lanjuan Li, Baohong Wang
Frontiers of Medicine (2022) Vol. 16, Iss. 5, pp. 667-685
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Qixing Nie, Xi Luo, Kai Wang, et al.
Cell (2024) Vol. 187, Iss. 11, pp. 2717-2734.e33
Open Access | Times Cited: 77
Mode of action of Akkermansia muciniphila in the intestinal dialogue: role of extracellular proteins, metabolites and cell envelope components
Anneleen Segers, Willem M. de Vos
Microbiome Research Reports (2023) Vol. 2, Iss. 2, pp. 6-6
Open Access | Times Cited: 30
Akkermansia muciniphila: A potential target and pending issues for oncotherapy
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 23
Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis
Wenjuan Wu, Xinhui Wu, Lingxiao Qiu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 7, pp. 4809-4822
Open Access | Times Cited: 13
The Reduced Gut Lachnospira Species Is Linked to Liver Enzyme Elevation and Insulin Resistance in Pediatric Fatty Liver Disease
Ching‐Chung Tsai, Min‐Hsi Chiu, Ho-Poh Kek, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3640-3640
Open Access | Times Cited: 5
Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease
Yiqing Hu, Xiaoyi Hu, Li Jiang, et al.
EBioMedicine (2024) Vol. 111, pp. 105482-105482
Open Access | Times Cited: 4
Peptidoglycan isolated from the fruit of Lycium barbarum alleviates liver fibrosis in mice by regulating the TGF-β/Smad7 signaling and gut microbiota
Yingmin Nie, Wanqi Zhou, Ting Niu, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Akkermansia muciniphila: promises and pitfallsfor next-generation beneficial microorganisms
Yantong Liu, Zonglun Li, Sze Ching Lee, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 4
Closed Access
Preventive mechanisms of Chinese Tibetan medicine Triphala against nonalcoholic fatty liver disease
Yan Jiang, Linlin Zhao, Jing Ma, et al.
Phytomedicine (2023) Vol. 123, pp. 155229-155229
Closed Access | Times Cited: 10
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Haoran Jiang, Linquan Zang
Current Pharmaceutical Design (2024) Vol. 30, Iss. 2, pp. 100-114
Closed Access | Times Cited: 3
Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin
Hongling Xu, Mingming Yuan, Kailin Niu, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 976-976
Open Access | Times Cited: 3
The worldview of Akkermansia muciniphila, a bibliometric analysis
Zhao Zhang, Jingyu Wang, S. J. Dang, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Decreased intestinal abundance of Akkermansia muciniphila is associated with metabolic disorders among people living with HIV
Zhe Qian, Suling Chen, Xiaoyang Liao, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Chronic jet lag alters gut microbiome and mycobiome and promotes the progression of MAFLD in HFHFD-fed mice
Ruoyi Zheng, Xingwei Xiang, Ying Shi, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Protective effects of phenylethanol glycosides from Cistanche tubulosa against ALD through modulating gut microbiota homeostasis
Zhaoyao Qi, Jincun Liu, Yuanhui Xu, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118925-118925
Closed Access | Times Cited: 2
Akkermansia muciniphila ONE effectively ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice
Hongyan Zhang, Yue Pan, Ying Jiang, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease
Chen Yao, Yumeng Gan, Huijie Zhong, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 6
Akkermansia muciniphila - A Potential Next-generation Probiotic for Non-alcoholic Fatty Liver Disease
Goutam Banerjee, Suraya R. Papri, Sanjaya K. Satapathy, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 4, pp. 426-433
Closed Access | Times Cited: 4
Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice
Naoya Igarashi, Kaichi Kasai, Yuki Tada, et al.
Inflammation Research (2024) Vol. 73, Iss. 7, pp. 1081-1098
Closed Access | Times Cited: 1
Lycorine ameliorates liver steatosis, oxidative stress, ferroptosis and intestinal homeostasis imbalance in MASLD mice
Ziwen Wang, Mengpei Zhu, Qian Li, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Roles of gut microbes in metabolic-associated fatty liver disease
Chun‐Yao Chen, Han‐Chen Ho
Tzu Chi Medical Journal (2023)
Open Access | Times Cited: 2
Inhibition of FoxO1 ameliorates hepatic steatosis and hepatitis in nonalcoholic steatohepatitis mice through regulation of gut microbiota
Di Wen Shou, Ying Quan, Jie Cheng, et al.
Journal of Digestive Diseases (2024) Vol. 25, Iss. 7, pp. 453-462
Closed Access
Akkermansia muciniphila in patients with metabolic dysfunction-associated steatotic liver disease
Adina Ioana Mihele, Liviu Lazăr
Journal of Medicine and Life (2024) Vol. 17, Iss. 9, pp. 880-885
Open Access
Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review
J. H. Ku, Jia‐Rou Hsu, Yung‐Tsung Li, et al.
Journal of Gastroenterology and Hepatology (2024)
Open Access
Longitudinal analysis of a dietary mouse model of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Marissa Saenz, Jillian C. McDonough, Elizabeth Bloom-Saldana, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1 - Next Page

Scroll to top